Literature DB >> 8209726

Fusogenic properties of uncleaved spike protein of murine coronavirus JHMV.

F Taguchi1, T Ikeda, K Saeki, H Kubo, T Kikuchi.   

Abstract

We have tested the fusogenic properties of cleaved and uncleaved spike (S) protein of murine coronavirus (MCV) JHMV variant cl-2 by expressing the S protein by recombinant vaccinia viruses (RVVs). The amino acid sequence of the putative cleavage site of cl-2 S protein, Arg-Arg-Ala-Arg-Arg, was replaced by Arg-Thr-Ala-Leu-Glu by in vitro mutagenesis of cl-2 S gene. The RVVs having cl-2 S gene [RVV t(+)] or mutated cl-2 S gene [RVV t(-)] were tested for their ability to induce fusion as well as cleavability in DBT cells. After inoculation with RVV t(+) onto DBT cells, the fusion formation was first observed at 8 h postinoculation (p.i.) and spread throughout the whole culture by 24 h. In cells infected with RVV t(-), fusion appeared by 2 h and most of cells were fused by 30 h p.i. The S protein and its cleavage products were detected in DBT cells expressing wild type S protein. However, no cleavage products of the S protein were detected in RVV t(-) infected cells producing mutated S protein, even though fusion was clearly visible. These results suggest that the cleavage event of JHMV-S protein of MCV is not a prerequisite for fusion formation, but that it enhances fusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8209726     DOI: 10.1007/978-1-4615-2996-5_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion.

Authors:  Cornelis A M de Haan; Konrad Stadler; Gert-Jan Godeke; Berend Jan Bosch; Peter J M Rottier
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Acquisition of cell-cell fusion activity by amino acid substitutions in spike protein determines the infectivity of a coronavirus in cultured cells.

Authors:  Yoshiyuki Yamada; Xiao Bo Liu; Shou Guo Fang; Felicia P L Tay; Ding Xiang Liu
Journal:  PLoS One       Date:  2009-07-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.